by Marina Kovaleva | Jun 4, 2024 | News
Almac Discovery, a research driven drug discovery company and member of the Almac Group, has announced the nomination of a new pre-clinical candidate molecule (ALM-401), a First in Class Bispecific Antibody Drug Conjugate (ADC) for the treatment of refractory lung...
by Marina Kovaleva | Apr 7, 2024 | News
Hear from Elasmogen’s CEO, Prof. Caroline Barelle, how The Scottish National Investment Bank helps to develop next-generation therapeutic drugs, with the potential to improve the health of people in Scotland and...
by Marina Kovaleva | Nov 17, 2023 | News
On 13th of November, as part of the Excelerate program, advanced higher biology students from Harlaw Academy visited Elasmogen. The students participated in interactive theory and practical sessions learning from Elasmogen’s scientists about fundamental ELISA and PCR...
by Marina Kovaleva | Jun 20, 2023 | News
Insider.co.uk has announced today the shortlist for the Deal & Dealmakers Awards. Elasmogen is nominated for Early Stage Deal of the Year in partnership with RBC Brewin Dolphin. Please see here the link to the story.
by Marina Kovaleva | Apr 28, 2023 | News
Elasmogen Ltd has announced the appointment of Jane Dancer as the Chair of the Board. Jane joined Elasmogen as a non-executive director in April 2022 on the back of new investment from BGF, The Bank and Scottish Enterprise who joined existing investors, Deepbridge...
